-
1
-
-
0032537990
-
Tamoxifen for prevention of breast cancer
-
Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study
-
Fisher B, Costantino JP, Wickerham DL, Redmond CK, Kavanah M, Cronin W, et al. Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst 1998;90:1371-88.
-
(1998)
J Natl Cancer Inst
, vol.90
, pp. 1371-1388
-
-
Fisher, B.1
Costantino, J.P.2
Wickerham, D.L.3
Redmond, C.K.4
Kavanah, M.5
Cronin, W.6
-
2
-
-
0030992308
-
Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden
-
Weitz IC, Israel VK, Liebman HA. Tamoxifen-associated venous thrombosis and activated protein C resistance due to factor V Leiden. Cancer 1997;79:2024-7.
-
(1997)
Cancer
, vol.79
, pp. 2024-2027
-
-
Weitz, I.C.1
Israel, V.K.2
Liebman, H.A.3
-
4
-
-
0141904693
-
Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer
-
Duggan C, Marriott K, Edwards R, Cuzick J. Inherited and acquired risk factors for venous thromboembolic disease among women taking tamoxifen to prevent breast cancer. J Clin Oncol 2003;21:3588-93.
-
(2003)
J Clin Oncol
, vol.21
, pp. 3588-3593
-
-
Duggan, C.1
Marriott, K.2
Edwards, R.3
Cuzick, J.4
-
5
-
-
0025981392
-
Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer
-
Saphner T, Tormey DC, Gray R. Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer. J Clin Oncol 1991;9:286-94.
-
(1991)
J Clin Oncol
, vol.9
, pp. 286-294
-
-
Saphner, T.1
Tormey, D.C.2
Gray, R.3
-
6
-
-
0029850530
-
A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
-
Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996;88:3698-703.
-
(1996)
Blood
, vol.88
, pp. 3698-3703
-
-
Poort, S.R.1
Rosendaal, F.R.2
Reitsma, P.H.3
Bertina, R.M.4
-
7
-
-
0028098210
-
Resistance to activated protein C as a basis for venous thrombosis
-
Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994;330:517-22.
-
(1994)
N Engl J Med
, vol.330
, pp. 517-522
-
-
Svensson, P.J.1
Dahlback, B.2
-
8
-
-
1842290346
-
Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis
-
Dahlback B. Resistance to activated protein C caused by the factor VR506Q mutation is a common risk factor for venous thrombosis. Thromb Haemost 1997;78:483-8.
-
(1997)
Thromb Haemost
, vol.78
, pp. 483-488
-
-
Dahlback, B.1
-
9
-
-
20244369707
-
The risk of recurrent venous thromboembolism in patients with and without factor V Leiden
-
Eichinger S, Pabinger I, Stumpfen A, Hirschl M, Bialonczyk C, Schneider B, et al. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden. Thromb Haemost 1997;77:624-8.
-
(1997)
Thromb Haemost
, vol.77
, pp. 624-628
-
-
Eichinger, S.1
Pabinger, I.2
Stumpfen, A.3
Hirschl, M.4
Bialonczyk, C.5
Schneider, B.6
-
10
-
-
0028029477
-
Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation
-
Vandenbroucke JP, Koster T, Briet D, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation. Lancet 1994;344:1453-7.
-
(1994)
Lancet
, vol.344
, pp. 1453-1457
-
-
Vandenbroucke, J.P.1
Koster, T.2
Briet, D.3
Reitsma, P.H.4
Bertina, R.M.5
Rosendaal, F.R.6
-
11
-
-
0027428481
-
Anticoagulant protein C pathway defective in majority of thrombophilic patients
-
Griffin JH, Evatt B, Wideman C, Fernadez JA. Anticoagulant protein C pathway defective in majority of thrombophilic patients. Blood 1993;82: 1989-93.
-
(1993)
Blood
, vol.82
, pp. 1989-1993
-
-
Griffin, J.H.1
Evatt, B.2
Wideman, C.3
Fernadez, J.A.4
-
12
-
-
0028931717
-
High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance)
-
Rosendaal FR, Koster T, Vandenbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995;85:1504-8.
-
(1995)
Blood
, vol.85
, pp. 1504-1508
-
-
Rosendaal, F.R.1
Koster, T.2
Vandenbroucke, J.P.3
Reitsma, P.H.4
-
13
-
-
0030797313
-
The Leiden Thrombophilia Study (LETS)
-
van der Meer FJ, Kaster T, Vandenbroucke JP, Briet E, Rosendaal FR. The Leiden Thrombophilia Study (LETS). Thromb Haemost 1997;78: 631-5.
-
(1997)
Thromb Haemost
, vol.78
, pp. 631-635
-
-
van der Meer, F.J.1
Kaster, T.2
Vandenbroucke, J.P.3
Briet, E.4
Rosendaal, F.R.5
-
14
-
-
0028810738
-
World distribution of factor V Leiden
-
Rees DC, Cox M, Clegg JB. World distribution of factor V Leiden. Lancet 1995;346:1133-4.
-
(1995)
Lancet
, vol.346
, pp. 1133-1134
-
-
Rees, D.C.1
Cox, M.2
Clegg, J.B.3
-
15
-
-
0036788617
-
Retrospective assessment of hypercoagulability in breast cancer prevention trial
-
Abramson N, Aster RH. Retrospective assessment of hypercoagulability in breast cancer prevention trial. J Clin Oncol 2002;20:4133-4.
-
(2002)
J Clin Oncol
, vol.20
, pp. 4133-4134
-
-
Abramson, N.1
Aster, R.H.2
-
16
-
-
0032521251
-
Rapid simultaneous screening of factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole blood
-
Gomez E, van der Poel SC, Jansen JH, van der Reijden BA, Lowenberg B. Rapid simultaneous screening of factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole blood. Blood 1998;91:2208-9.
-
(1998)
Blood
, vol.91
, pp. 2208-2209
-
-
Gomez, E.1
van der Poel, S.C.2
Jansen, J.H.3
van der Reijden, B.A.4
Lowenberg, B.5
-
17
-
-
33745789157
-
-
4th ed. Belmont (CA): Wadsworth
-
Rosner B. Fundamentals of biostatistics. 4th ed. Belmont (CA): Wadsworth; 1995. p. 590-4.
-
(1995)
Fundamentals of Bostatistics
, pp. 590-594
-
-
Rosner, B.1
-
18
-
-
0026562206
-
Applications of crude incidence curves
-
Korn J, Dorey FJ. Applications of crude incidence curves. Stat Med 1992; 11:813-29.
-
(1992)
Stat Med
, vol.11
, pp. 813-829
-
-
Korn, J.1
Dorey, F.J.2
-
19
-
-
33845248846
-
Inference for events with dependent risks in multiple endpoint studies
-
Pepe MS. Inference for events with dependent risks in multiple endpoint studies. J Am Stat Assoc 1991;86:770-8.
-
(1991)
J Am Stat Assoc
, vol.86
, pp. 770-778
-
-
Pepe, M.S.1
-
21
-
-
0035176945
-
Venous thromboembolism and hormone replacement therapy
-
Mannucci PM. Venous thromboembolism and hormone replacement therapy. Eur J Intern Med 2001;12:478-83.
-
(2001)
Eur J Intern Med
, vol.12
, pp. 478-483
-
-
Mannucci, P.M.1
-
22
-
-
0031868669
-
Oral contraceptives and venous thromboembolism. A case-control study
-
Lidegaard O, Edstrom B, Kreiner S. Oral contraceptives and venous thromboembolism. A case-control study. Contraception 1998;57:291-301.
-
(1998)
Contraception
, vol.57
, pp. 291-301
-
-
Lidegaard, O.1
Edstrom, B.2
Kreiner, S.3
-
23
-
-
0034595197
-
Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The heart and estrogen/progestin replacement study
-
Grady D, Wenger NK, Herrington D, Khan S, Furberg C, Hunninghake D, et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The heart and estrogen/progestin replacement study. Ann Intern Med 2000;132:689-96.
-
(2000)
Ann Intern Med
, vol.132
, pp. 689-696
-
-
Grady, D.1
Wenger, N.K.2
Herrington, D.3
Khan, S.4
Furberg, C.5
Hunninghake, D.6
-
24
-
-
0035489312
-
Hypercoagulability: Clinical assessment and treatment
-
Abramson N, Abramson S. Hypercoagulability: Clinical assessment and treatment. South Med J 2001;94:1013-20.
-
(2001)
South Med J
, vol.94
, pp. 1013-1020
-
-
Abramson, N.1
Abramson, S.2
-
25
-
-
0032190251
-
Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: A study of 150 families
-
Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F, et al. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia: A study of 150 families. Blood 1998;92: 2353-8.
-
(1998)
Blood
, vol.92
, pp. 2353-2358
-
-
Martinelli, I.1
Mannucci, P.M.2
De Stefano, V.3
Taioli, E.4
Rossi, V.5
Crosti, F.6
-
26
-
-
0037219744
-
Effect of tamoxifen on venous thrombosis risk factors in women without cancer
-
The Breast Cancer Prevention Trial
-
Cushman M, Costantino JP, Bovill EG, Wickerham DL, Buckley L, Roberts JD, et al. Effect of tamoxifen on venous thrombosis risk factors in women without cancer: The Breast Cancer Prevention Trial. Br J Haematol 2003;120:109-16.
-
(2003)
Br J Haematol
, vol.120
, pp. 109-116
-
-
Cushman, M.1
Costantino, J.P.2
Bovill, E.G.3
Wickerham, D.L.4
Buckley, L.5
Roberts, J.D.6
|